Erin N Schoenfelder1,2, Andrea Chronis-Tuscano3, Jennifer Strickland2, Daniel Almirall4, Mark A Stein1,2. 1. 1 Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington. 2. 2 Center for Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle, Washington. 3. 3 Department of Psychology, University of Maryland, College Park, Maryland. 4. 4 Department of Statistics, University of Michigan, Ann Arbor, Michigan.
Abstract
Objective: Parental attention-deficit/hyperactivity disorder (ADHD) is associated with suboptimal parenting and reduces the effectiveness of child ADHD treatments. We conducted a Pilot Sequential, Multiple Assignment, Randomized Trial (SMART Pilot) to evaluate the feasibility and acceptability of sequencing medication and behavioral treatments for mothers with ADHD to target outcomes, including maternal ADHD, parenting, and child ADHD symptoms/impairment in multiplex ADHD families. Methods: Thirty-five mothers with ADHD and their 5- to 8-year-old child with ADHD symptoms were enrolled. Mothers were randomized to 8 weeks of individually titrated stimulant medication (MSM) or behavioral parent training (BPT), followed by rerandomization to 8 weeks of continued first-line treatment (with as-needed modifications) or combined treatment, leading to four treatment sequences (MSM-MSM, MSM-BPT, BPT-MSM, and BPT-BPT). Results: Recruitment of multiplex ADHD families came primarily from child providers. Mothers were adherent to medication and had high therapy session attendance. Mothers and clinicians found both treatments to be acceptable and preferred combination treatment, especially receiving medication before BPT. Monotherapy treatment visits were viewed as more burdensome (MSM-MSM, BPT-BPT). Conclusions: Maternal stimulant medication and BPT are acceptable and feasible interventions for families in which both the mother and child have ADHD symptoms. Mothers with concerns about their children's ADHD symptoms are receptive to receiving treatment themselves as an initial strategy for improving their children's health and functioning. Fully powered SMART designs show promise in evaluating the sequencing of interventions and helping clinicians develop algorithms for treating multiplex families in real-world practice settings.
RCT Entities:
Objective: Parental attention-deficit/hyperactivity disorder (ADHD) is associated with suboptimal parenting and reduces the effectiveness of childADHD treatments. We conducted a Pilot Sequential, Multiple Assignment, Randomized Trial (SMART Pilot) to evaluate the feasibility and acceptability of sequencing medication and behavioral treatments for mothers with ADHD to target outcomes, including maternal ADHD, parenting, and childADHD symptoms/impairment in multiplex ADHD families. Methods: Thirty-five mothers with ADHD and their 5- to 8-year-old child with ADHD symptoms were enrolled. Mothers were randomized to 8 weeks of individually titrated stimulant medication (MSM) or behavioral parent training (BPT), followed by rerandomization to 8 weeks of continued first-line treatment (with as-needed modifications) or combined treatment, leading to four treatment sequences (MSM-MSM, MSM-BPT, BPT-MSM, and BPT-BPT). Results: Recruitment of multiplex ADHD families came primarily from child providers. Mothers were adherent to medication and had high therapy session attendance. Mothers and clinicians found both treatments to be acceptable and preferred combination treatment, especially receiving medication before BPT. Monotherapy treatment visits were viewed as more burdensome (MSM-MSM, BPT-BPT). Conclusions: Maternal stimulant medication and BPT are acceptable and feasible interventions for families in which both the mother and child have ADHD symptoms. Mothers with concerns about their children's ADHD symptoms are receptive to receiving treatment themselves as an initial strategy for improving their children's health and functioning. Fully powered SMART designs show promise in evaluating the sequencing of interventions and helping clinicians develop algorithms for treating multiplex families in real-world practice settings.
Authors: Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser Journal: Pediatrics Date: 2011-10-16 Impact factor: 7.124
Authors: Daniel Almirall; Scott N Compton; Meredith Gunlicks-Stoessel; Naihua Duan; Susan A Murphy Journal: Stat Med Date: 2012-03-22 Impact factor: 2.373
Authors: James G Waxmonsky; D A Waschbusch; D E Babinski; H H Humphrey; A Alfonso; K I Crum; M Bernstein; J Slavec; J N Augustus; W E Pelham Journal: CNS Drugs Date: 2014-07 Impact factor: 5.749
Authors: Howard Abikoff; L Eugene Arnold; Jeffrey H Newcorn; Glen R Elliott; Lily Hechtman; Joanne B Severe; Timothy Wigal; Cheri Shapiro; Dennis P Cantwell; C Keith Conners; Laurence L Greenhill; Stephen P Hinshaw; Betsy Hoza; Peter S Jensen; Helena C Kraemer; John S March; William E Pelham; James M Swanson; Benedetto Vitiello; Karen C Wells Journal: J Am Acad Child Adolesc Psychiatry Date: 2002-05 Impact factor: 8.829
Authors: Ronald C Kessler; Lenard Adler; Russell Barkley; Joseph Biederman; C Keith Conners; Olga Demler; Stephen V Faraone; Laurence L Greenhill; Mary J Howes; Kristina Secnik; Thomas Spencer; T Bedirhan Ustun; Ellen E Walters; Alan M Zaslavsky Journal: Am J Psychiatry Date: 2006-04 Impact factor: 18.112
Authors: Michael E Thase; Edward S Friedman; Melanie M Biggs; Stephen R Wisniewski; Madhukar H Trivedi; James F Luther; Maurizio Fava; Andrew A Nierenberg; Patrick J McGrath; Diane Warden; George Niederehe; Steven D Hollon; A John Rush Journal: Am J Psychiatry Date: 2007-05 Impact factor: 18.112
Authors: Yuhuan Xie; J Faye Dixon; Ong Min Yee; Junshun Zhang; Y Ann Chen; Sascha Deangelo; Peter Yellowlees; Robert Hendren; Julie B Schweitzer Journal: Telemed J E Health Date: 2013-02-13 Impact factor: 3.536
Authors: Andrea Chronis-Tuscano; Veronica L Raggi; Tana L Clarke; Mary E Rooney; Yamalis Diaz; Jessica Pian Journal: J Abnorm Child Psychol Date: 2008-11
Authors: Ping C Mamiya; Todd L Richards; Richard A E Edden; Adrian K C Lee; Mark A Stein; Patricia K Kuhl Journal: Int J Mol Sci Date: 2022-04-23 Impact factor: 6.208
Authors: Cindy Ola; Erin Gonzalez; Nguyen Tran; Tyler Sasser; Michelle Kuhn; Patrick A LaCount; Mark A Stein; Jason A Mendoza; Pooja S Tandon Journal: J Pediatr Psychol Date: 2021-07-20